IRWD

Conviction 85HealthcareScan · Thu, Sep 24, 2026

Ironwood Pharmaceuticals Inc (IRWD) closed at $4.20 (-1.64%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 49, RS Rating 98, -22.1% from its 52-week high, -1.6% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

IRWD$4.20-1.64%

ResistanceSupportVol 14Insider sell

Vol MA14 2.38M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

IRONWOOD PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.ironwoodpharma.com ↗

Price4.20

Change-1.64%

Gap-0.70%

Rel volume2.00×

Avg volume2.13M

Avg $ vol9.07M

SMA 204.23

SMA 504.15

SMA 2003.99

Price vs 50+1.24%

Price vs 200+5.33%

MA stackbullish

50/200 cross—

Supertrendup · 3.89

RSI (14)49

MACD hist0.01

MACD crossbull · 4d

Stoch %K / %D40 / 60

ADX (14)12

+DI / −DI23 / 25

RSI divergence—

MACD divergenceBearish

ATR %5.04%

ADR %4.33%

52w high5.39

52w low1.27

From 52w high-22.08%

Above 52w low+230.71%

New 52w highNo

SqueezeOn · 21d

Bollinger width12.39%

%B0.45

Donchian pos39.69%

Donchian high4.60

Donchian low3.94

AVWAP (52w high)4.16

vs AVWAP high+1.04%

AVWAP (52w low)3.85

vs AVWAP low+8.96%

OBV trendUp

Chaikin MF (20)0.13

Today vs 20d2.00×

Avg vol (14d)2.38M

Avg vol (20d)2.13M

Avg $ vol (20d)9.07M

Market cap694.01M

RS Rating98 / 99

RS 3m (vs SPY)+4.88%

RS 6m (vs SPY)+14.84%

RS line new highNo

Trend template6/8

Technical rank72.2

1 week-0.71%

1 month-4.33%

3 months+9.38%

6 months+31.66%

1 year+202.16%

YTD-1.64%

P/E28.90

P/B-4.29

P/S2.34

P/FCF5.46

EPS0.1500

Div yield—

ROE-14.84%

ROA8.42%

Debt/Eq-1.98

Current6.06

EV/EBITDA9.39

Gross margin—

Net margin8.11%

Rev growth-15.72%

EPS growth2629.20%

Price target—

Target upside—

Analyst rating—

Institutional108.92%

Ent. value935.09M

Revenue113.04M

Net income51.29M

Gross profit—

Free cash flow127.01M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out164.61M

Employees100

ListedWed, Feb 3, 2010

Free float149.44M

Float %90.8%

Short interest17.65M

Days to cover11.9d

Short volume64.8%

Squeeze score80 / 100

Next earnings—

EPS forecast—

Last EPS vs est$0.31 vs $0.26

Last surprise+19.2% beat

Setup gradeA+

Conviction85 / 100

Pattern quality—

Tech rank72.2 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.59

Support3.93

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IRWD

All disclosures →

No recent disclosed trades by Congress in IRWD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IRWD · open-market 1 sell

Insider	Side	Shares	Value	Traded	Filed
DENNER ALEXANDER J Director · Class A Common Stock · 2026-09-15	Grant	3.69K	—	2026-09-15	2026-09-17
Silber Jeffrey SVP, CMO, Head-Res&Drug · Class A Common Stock · 2026-07-20	Grant	137.04K	—	2026-07-20	2026-07-22
Silver Ronald PFO & PAO · Class A Common Stock · 2026-07-07	Sell	127.89K	$578K	2026-07-07	2026-07-09
Silver Ronald PFO & PAO · Common Stock · 2026-05-19	Grant	25K	$0	2026-05-19	2026-05-21

SEC filings

EDGAR filings in IRWD · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.